Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126151671 | 12615167 | 1 | I | 20160728 | 20160802 | 20160802 | EXP | FR-ROCHE-1804459 | ROCHE | 0.00 | F | Y | 58.00000 | KG | 20160802 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126151671 | 12615167 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | LAST DOSE PRIOR TO SAE: 26/APR/2016 | 125085 | 320 | MG | ||||||||
| 126151671 | 12615167 | 2 | SS | Atezolizumab | ATEZOLIZUMAB | 1 | Unknown | LAST DOSE PRIOR TO SAE: 26/APR/2016 | 761034 | ||||||||||
| 126151671 | 12615167 | 3 | SS | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Unknown | LAST DOSE PRIOR TO SAE: 26/APR/2016 | 0 | 322 | MG | ||||||||
| 126151671 | 12615167 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous bolus | LAST DOSE OF BOLUS PRIOR TO SAE: 17/NOV/2015 | 0 | 644 | MG | ||||||||
| 126151671 | 12615167 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous drip | LAST DOSE PRIOR TO INFUSION: 28/APR//2016 | 0 | 3864 | MG | ||||||||
| 126151671 | 12615167 | 6 | SS | OXALIPLATINE | OXALIPLATIN | 1 | Unknown | LAST DOSE PRIOR TO SAE: 20/OCT/2015. | 0 | 136.85 | MG | ||||||||
| 126151671 | 12615167 | 7 | C | LYRICA | PREGABALIN | 1 | Unknown | 0 | 150 | MG | |||||||||
| 126151671 | 12615167 | 8 | C | ESIDREX | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | 25 | MG | |||||||||
| 126151671 | 12615167 | 9 | C | AMLOR | AMLODIPINE BESYLATE | 1 | Unknown | 0 | 5 | MG | |||||||||
| 126151671 | 12615167 | 10 | C | ELISOR | PRAVASTATIN SODIUM | 1 | Unknown | 0 | 20 | MG | |||||||||
| 126151671 | 12615167 | 11 | C | FIXICAL | CALCIUM CARBONATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126151671 | 12615167 | 1 | Colorectal cancer |
| 126151671 | 12615167 | 2 | Colorectal cancer |
| 126151671 | 12615167 | 3 | Colorectal cancer |
| 126151671 | 12615167 | 4 | Colorectal cancer |
| 126151671 | 12615167 | 6 | Colorectal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126151671 | 12615167 | DE |
| 126151671 | 12615167 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126151671 | 12615167 | Multiple organ dysfunction syndrome | |
| 126151671 | 12615167 | Pyrexia | |
| 126151671 | 12615167 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126151671 | 12615167 | 1 | 20150811 | 0 | ||
| 126151671 | 12615167 | 2 | 20151208 | 0 | ||
| 126151671 | 12615167 | 3 | 20150811 | 0 | ||
| 126151671 | 12615167 | 4 | 20150811 | 0 | ||
| 126151671 | 12615167 | 5 | 20150811 | 0 | ||
| 126151671 | 12615167 | 6 | 20150811 | 0 |